Goldman Sachs analyst Jami Rubin’s dream of a Johnson & Johnson break-up will not be deterred. In what amounts to a 23-page wish list, the analyst laid out reasons for breaking up the company in...
Latest dehydration tool is a pressurized fluid reservoir
By
Elizabeth Newman
Jun 05, 2015
Despite dozens of studies on dehydration in the elderly, little research offers conclusive advice on how to solve the problem. A new device hopes to help by using a system that sprays high volumes of fluid...
On-demand payments help healthcare workers’ finances
By
Amy Novotney
Feb 01, 2024
Healthcare workers who leverage the earned wage access solution DailyPay reduce their credit card debt, pay fewer late fees on bills, use payday loans less often and pay fewer overdraft fees.
Longevity-Humana launches I-SNP in Texas
By
Amy Novotney
Dec 07, 2023
The managed care partnership between Longevity Health Plan and Humana has entered a new caregiving collaboration with Touchstone Communities, which offers skilled nursing, memory care and rehabilitation...
FDA approves first biosimilar treatment
By
Elizabeth Newman
Apr 06, 2015
The Food and Drug Administration approved its first biosimilar product in March, opening the door for more costly drug alternatives.
PharMerica to be acquired by KKR in $1.4B deal; Walgreens will a be minority investor
By
Elizabeth Newman
Sep 06, 2017
Global investment firm KKR will buy PharMerica Corporation in a $1.4 billion deal, the companies announced in August.
The acquisition of Vikus Corporation by HealthcareSource has resulted in an integrated platform with plans to continue further investments, HealthcareSource CEO J.P. Fingado said in January. When Fingado...
BrightSpring Health Services, the parent company of long-term care pharmacy PharMerica, began trading on the Nasdaq in January using the symbol BTSG, following the pricing of its initial public offering.
September Company Briefs
Sep 01, 2020
DrFirst and PointClickCare have partnered to bring the telehealth and communication platform Backline to long-term care providers that are located in North America.
FDA wants lower doses for sleeping aids
By
Elizabeth Newman
Feb 01, 2013
The Food and Drug Administration is requiring manufacturers of certain sleeping pills, including the widely prescribed Ambien, to reduce current recommended dosages.